Mesoblast
MESO
$7.35
Share price
4.70%
Change (1 day)
91.91%
Change (1 year)
Categories
Mesoblast (MESO) - Net assets
Net assets on the balance sheet as of June 2023 : $0.50 B
According to Mesoblast
's latest financial reports the company has $0.50 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Mesoblast - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-06-30 | $0.50 B | 0.96% |
| 2022-06-30 | $0.49 B | -14.51% |
| 2021-06-30 | $0.58 B | 5.84% |
| 2020-06-30 | $0.54 B | 14.19% |
| 2019-06-30 | $0.48 B | -11.9% |
| 2018-06-30 | $0.54 B | 5.66% |
| 2017-06-30 | $0.51 B | -2.16% |
| 2016-06-30 | $0.52 B | 12.86% |
| 2015-06-30 | $0.46 B | -18.14% |
| 2014-06-30 | $0.57 B | -9.29% |
| 2013-06-30 | $0.63 B | 31.62% |
| 2012-06-30 | $0.47 B | -7.17% |
| 2011-06-30 | $0.51 B | 1260.38% |
| 2010-06-30 | $37.91 M | 47.03% |
| 2009-06-30 | $25.78 M | -1.63% |
| 2008-06-30 | $26.21 M | 27.64% |
| 2007-06-30 | $20.53 M | 71.66% |
| 2006-06-30 | $11.96 M | -37.89% |
| 2005-06-30 | $19.26 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.88 M | -100.57% | Bahamas |
 NRC Health
NRC | $48.95 M | -90.24% | 🇺🇸 USA |